Seeing Is Believing
with an average price target of $5.21. This is a potential upside of $5.21 (0%) from yesterday's end of day stock price of $0.
Progenics Pharmaceuticals's activity chart (see below) currently has 16 price targets and 14 ratings on display.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 155.25 days.
Most recent stock forecast was given by CHAD MESSER from NEEDHAM on 14-Mar-2019. First documented stock forecast 12-Mar-2008.
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
10
$5.9 (143.90%)
12
5 years 15 days ago
3/9 (33.33%)
$5.58 (126.24%)
321
Buy
11
$6.9 (168.29%)
9
7 years 2 months 18 days ago
3/3 (100%)
$2.1 (23.60%)
165
Buy
11
$6.9 (168.29%)
11
7 years 5 months 2 days ago
2/3 (66.67%)
$5.29 (81.82%)
135
Buy
14
$9.9 (241.46%)
14
7 years 8 months 9 days ago
0/2 (0%)
$7.86 (128.01%)
What is PGNX (Progenics Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on PGNX (Progenics Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on PGNX (Progenics Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PGNX (Progenics Pharmaceuticals)?
Which analyst is the currently most bullish on PGNX (Progenics Pharmaceuticals)?
Which analyst is the currently most reserved on PGNX (Progenics Pharmaceuticals)?